Specific walking patterns in people living with multiple sclerosis
Official title: Investigating Specific Gait Patterns in Individuals Living With Multiple Sclerosis
Run by Sysnav · NCT07388992 · Data updated 2026-11-12
This project will see if people with multiple sclerosis have specific walking patterns compared with healthy adults.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Sysnav Industry-sponsored |
| Locations | 1 site (Lille) |
| Status | Recruiting |
| Started | March 16, 2026 |
| Main results expected | June 2026 |
| Study ends | June 2026 |
| Registry record updated | March 23, 2026 |
| Trial ID | NCT07388992 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–65 with a confirmed MS diagnosis, EDSS ≤6, stable on therapy for at least two months, able to comply with study procedures and attend visits at CHU Lille are the ideal candidates.
✕Probably not a fit
People with more advanced disability beyond EDSS 6, those unable to travel to Lille, or those seeking immediate treatment changes are unlikely to receive direct clinical benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project at CHU Lille will compare walking patterns between adults with multiple sclerosis and healthy volunteers. Participants (ages 18–65) with a confirmed MS diagnosis according to McDonald 2017 and EDSS of 6 or lower who have been on stable treatment for at least two months will complete standardized gait evaluations. Age-matched healthy volunteers will complete the same walking tests as controls. The study will use objective gait measurements and clinical walking tasks to characterize ambulation quality.
Why it matters
Potential benefit: If successful, this could help clinicians track walking changes in MS more precisely and guide personalized rehabilitation.
How similar studies have gone: Previous gait-analysis research in multiple sclerosis has identified characteristic walking abnormalities, so this work builds on established findings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: For people living with multiple sclerosis (pwMS): 1. Age at inclusion between =18 and =65 years old 2. Signed informed consent and ability to comply with study and follow-up. 3. Confirmed MS diagnosis according to McDonald criteria (2017) 4. Expanded Disability Status Scale EDSS = 6 5. Stable treatment for 2 months before inclusion (for both disease modifying and symptomatic therapies) 6. Ability and willingness to participate in and comply with all study procedures defined in the protocol 7. Subject will be eligible for enrollment in this study only if either affiliated to, or a beneficiary of a social security category For Healthy volunteers : 1. Age at inclusion between =18 and =65 years old 2. Signed informed consent and ability to comply with study and follow-up. 3. Ability and willingness to participate in and comply with all study procedures defined in the protocol 4. Subject will be eligible for enrollment in this study only if either affiliated to, or a beneficiary of a social security category Exclusion Criteria: For pwMS: 1. Participants with a relapse within the past 3 months before the inclusion 2. Participants with significant cognitive disorders, limiting the understanding of the exercises to be performed or presence of apparent communication difficulties hindering the correct collection of data, as assessed by the investigator 3. Past or present pathology other than MS or surgery or trauma impacting gait, ambulatory function or upper limb function, as assessed by the investigator 4. Vulnerable adults: individuals subject to a legal protection measure (guardianship, limited guardianship, or judicial protection) or unable to express their consent. For healthy volunteers (HV): 1. Participants with significant cognitive disorders, limiting the understanding of the exercises to be performed or presence of apparent communication difficulties hindering the correct collection of data, as assessed by the investigator 2. Past or present pathology or surgery or trauma impacting gait, ambulatory function or upper limb function, as assessed by the investigator 3. Vulnerable adults: individuals subject to a legal protection measure (guardianship, limited guardianship, or judicial protection) or unable to express their consent.
Where it's running
-
CHU Lille
Lille, France Recruiting
Study contacts
- Principal investigator: Patrick Vermersch — CHU Lille
- Study coordinator: Ferial Toumi
- Email: ferial.toumi@sysnav.fr
- Phone: +33 2 78 00 10 98
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
Oura Ring validation for sleep using gold-standard sleep tests
This study tests how well the Oura Ring matches the gold-standard sleep test ( PSG ) in healthy adults and people with sleep apnea.
-
Magnetic field maps with NV sensors for non-invasive heart measurements
This study tests whether diamond-based NV magnetometers can non-invasively detect and map the heart's magnetic field in healthy adults.
-
Cognitive Tasks and Models in a Large Online Sample
This study tests cognitive tasks and computational models in a large online group to see if these tools can help predict symptoms like hallucinations and delusions in the general population.
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.